Kiniksa Pharmaceuticals International (KNSA) Tax Rate (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) posted Tax Rate of 30.87% for Q1 2026, up 164.27% on a QoQ basis from 48.03% in Q4 2025, and down 1427.0% year-over-year from 2.33% in Q1 2025.
Kiniksa Pharmaceuticals International (KNSA) Tax Rate (2017 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International's Tax Rate history runs 10 years deep, the most recent figure standing at 30.87% for Q1 2026.
- Quarterly Tax Rate fell 1427.0% year-over-year to 30.87% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13.58% (down 3442.0% YoY) and the FY2025 annual result came in at 12.72%, up 10447.0% from the prior year.
- Tax Rate was 30.87% for Q1 2026 at Kiniksa Pharmaceuticals International, up from 48.03% in the prior quarter.
- Across five years, Tax Rate topped out at 1308.39% in Q2 2023 and bottomed at 379.5% in Q3 2022.
- A 5-year average of 45.64% and a median of 15.27% in 2023 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2023 — Tax Rate jumped 131211 bps — and 2024, when it tumbled 103878 bps.
- Kiniksa Pharmaceuticals International's Tax Rate stood at 212.88% in 2022, then surged by 93 bps to 15.27% in 2023, then slumped by 361 bps to 70.36% in 2024, then surged by 32 bps to 48.03% in 2025, then soared by 164 bps to 30.87% in 2026.
- Business Quant data shows KNSA's Tax Rate at 30.87% in Q1 2026, 48.03% in Q4 2025, and 32.12% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 15.33% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.71% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -23.33% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 13.63% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 171.33% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 19.81% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 34.48% |
| 10 | Kiniksa Pharmaceuticals International | 4.82 Bn | 4.36 Bn | 193.47 Mn | 30.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.87% |
| Mar 31, 2026 | 30.87% |
| Mar 31, 2026 | 30.87% |
| Dec 31, 2025 | -48.03% |
| Dec 31, 2025 | -48.03% |
| Dec 31, 2025 | -48.03% |
| Sep 30, 2025 | 32.12% |
| Sep 30, 2025 | 32.12% |
| Sep 30, 2025 | 32.12% |
| Jun 30, 2025 | 22.05% |
| Jun 30, 2025 | 22.05% |
| Jun 30, 2025 | 22.05% |
| Mar 31, 2025 | 45.14% |
| Mar 31, 2025 | 45.14% |
| Mar 31, 2025 | 45.14% |
| Dec 31, 2024 | -70.36% |
| Dec 31, 2024 | -70.36% |
| Dec 31, 2024 | -70.36% |
| Sep 30, 2024 | -76.27% |
| Sep 30, 2024 | -76.27% |